Inhibitor of κB Kinase Beta Regulates Gastric Carcinogenesis via Interleukin-1α Expression

Gastroenterology

Volumn 139, Issue 1, 2010, Pages

  Sakamoto, Kei ^a   Hikiba, Yohko ^a   Nakagawa, Hayato ^b   Hayakawa, Yoku ^b   Yanai, Ayako ^a   Akanuma, Masao ^a   Ogura, Keiji ^b   Hirata, Yoshihiro ^b   Kaestner, Klaus H ^c   Omata, Masao ^b   Maeda, Shin ^b  

^a INSTITUTE FOR ADULT DISEASES   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c Institute for Diabetes   (United States)

Author keywords

Gastric Cancer; IKK ; Inflammation; NF B

Indexed keywords

DNA FRAGMENT; I KAPPA B KINASE BETA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; METHYLNITROSOUREA; PROTEIN BCL 2; SMALL INTERFERING RNA; TUMOR NECROSIS FACTOR ALPHA; I KAPPA B KINASE; INTERLEUKIN 1 RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CANCER INCIDENCE; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE RELEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; FORESTOMACH; GEL MOBILITY SHIFT ASSAY; HELICOBACTER INFECTION; HISTOPATHOLOGY; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; KNOCKOUT MOUSE; MOUSE; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPLEEN; STOMACH CANCER; STOMACH CARCINOGENESIS; STOMACH EPITHELIUM; SURVIVAL RATE; TUMOR VOLUME; ANIMAL; C57BL MOUSE; GENETICS; HUMAN; MOUSE MUTANT; PATHOLOGY; PHYSIOLOGY; STOMACH TUMOR; TUMOR CELL LINE;

ANIMALS; APOPTOSIS; CELL LINE, TUMOR; CELL PROLIFERATION; HUMANS; I-KAPPA B KINASE; INTERLEUKIN-1ALPHA; METHYLNITROSOUREA; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NF-KAPPA B; RECEPTORS, INTERLEUKIN-1; STOMACH NEOPLASMS;

EID: 77953908026     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2010.03.047     Document Type: Article

References (35)

1. Maeda S., and Omata M. Inflammation and cancer: Role of nuclear factor-kappaB activation. Cancer Sci 99 (2008) 836-842
2. Coussens L.M., and Werb Z. Inflammation and cancer. Nature 420 (2002) 860-867
3. Karin M., Cao Y., Greten F.R., et al. NF-kappaB in cancer: from innocent bystander to major culprit. Nat Rev Cancer 2 (2002) 301-310
4. Ghosh S., and Karin M. Missing pieces in the NF-kappaB puzzle. Cell 109 Suppl (2002) S81-S96
5. Li Z.-W., Chu W., Hu Y., et al. The IKKb subunit of IkB kinase (IKK) is essential for NF-kB activation and prevention of apoptosis. J Exp Med 189 (1999) 1839-1845
6. Greten F.R., Eckmann L., Greten T.F., et al. IKKbeta links inflammation and tumorigenesis in a mouse model of colitis-associated cancer. Cell 118 (2004) 285-296
7. Pikarsky E., Porat R.M., Stein I., et al. NF-kappaB functions as a tumour promoter in inflammation-associated cancer. Nature 431 (2004) 461-466
8. Maeda S., Kamata H., Luo J.L., et al. IKKbeta couples hepatocyte death to cytokine-driven compensatory proliferation that promotes chemical hepatocarcinogenesis. Cell 121 (2005) 977-990
9. Dajee M., Lazarov M., Zhang J.Y., et al. NF-kappaB blockade and oncogenic Ras trigger invasive human epidermal neoplasia. Nature 421 (2003) 639-643
10. Tsugane S., and Sasazuki S. Diet and the risk of gastric cancer: review of epidemiological evidence. Gastric Cancer 10 (2007) 75-83
11. Jakszyn P., Bingham S., Pera G., et al. Endogenous versus exogenous exposure to N-nitroso compounds and gastric cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC-EURGAST) study. Carcinogenesis 27 (2006) 1497-1501
12. Parsonnet J., Hansen S., Rodriguez L., et al. Helicobacter pylori infection and gastric lymphoma. N Engl J Med 330 (1994) 1267-1271
13. Uemura N., Okamoto S., Yamamoto S., et al. Helicobacter pylori infection and the development of gastric cancer. N Engl J Med 345 (2001) 784-789
14. Maeda S., Yoshida H., Ogura K., et al. H. pylori activates NF-kappaB through a signaling pathway involving IkappaB kinases, NF-kappaB-inducing kinase, TRAF2, and TRAF6 in gastric cancer cells. Gastroenterology 119 (2000) 97-108
15. Keates S., Hitti Y.S., Upton M., et al. Helicobacter pylori infection activates NF-kappa B in gastric epithelial cells. Gastroenterology 113 (1997) 1099-1109
16. Li Z.W., Omori S.A., Labuda T., et al. IKK beta is required for peripheral B cell survival and proliferation. J Immunol 170 (2003) 4630-4637
17. Lee C.S., Sund N.J., Behr R., et al. Foxa2 is required for the differentiation of pancreatic alpha-cells. Dev Biol 278 (2005) 484-495
18. Yamachika T., Nakanishi H., Inada K., et al. N-methyl-N-nitrosourea concentration-dependent, rather than total intake-dependent, induction of adenocarcinomas in the glandular stomach of BALB/c mice. Jpn J Cancer Res 89 (1998) 385-391
19. Habraken Y., and Piette J. NF-kappaB activation by double-strand breaks. Biochem Pharmacol 72 (2006) 1132-1141
20. Shibata W., Maeda S., Hikiba Y., et al. c-Jun NH2-terminal kinase 1 is a critical regulator for the development of gastric cancer in mice. Cancer Res 68 (2008) 5031-5039
21. De Smaele E., Zazzeroni F., Papa S., et al. Induction of gadd45beta by NF-kappaB downregulates pro-apoptotic JNK signalling. Nature 414 (2001) 308-313
22. Kamata H., Honda S., Maeda S., et al. Reactive oxygen species promote TNFalpha-induced death and sustained JNK activation by inhibiting MAP kinase phosphatases. Cell 120 (2005) 649-661
23. Tache Y., and Saperas E. Potent inhibition of gastric acid secretion and ulcer formation by centrally and peripherally administered interleukin-1. Ann N Y Acad Sci 664 (1992) 353-368
24. Ito R., Kitadai Y., Kyo E., et al. Interleukin 1 alpha acts as an autocrine growth stimulator for human gastric carcinoma cells. Cancer Res 53 (1993) 4102-4106
25. El-Omar E.M., Carrington M., Chow W.H., et al. Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature 404 (2000) 398-402
26. Li X., Eckard J., Shah R., et al. Interleukin-1alpha up-regulation in vivo by a potent carcinogen 7,12-dimethylbenz(a)anthracene (DMBA) and control of DMBA-induced inflammatory responses. Cancer Res 62 (2002) 417-423
27. Tu S., Bhagat G., Cui G., et al. Overexpression of interleukin-1beta induces gastric inflammation and cancer and mobilizes myeloid-derived suppressor cells in mice. Cancer Cell 14 (2008) 408-419
28. Sakurai T., He G., Matsuzawa A., et al. Hepatocyte necrosis induced by oxidative stress and IL-1 alpha release mediate carcinogen-induced compensatory proliferation and liver tumorigenesis. Cancer Cell 14 (2008) 156-165
29. Hanahan D., and Weinberg R.A. The hallmarks of cancer. Cell 100 (2000) 57-70
30. O'Neill L. The Toll/interleukin-1 receptor domain: a molecular switch for inflammation and host defence. Biochem Soc Trans 28 (2000) 557-563
31. Ogura K., Maeda S., Nakao M., et al. Virulence factors of Helicobacter pylori responsible for gastric diseases in Mongolian gerbil. J Exp Med 192 (2000) 1601-1610
32. Yanai A., Maeda S., Shibata W., et al. Activation of IkappaB kinase and NF-kappaB is essential for Helicobacter pylori-induced chronic gastritis in Mongolian gerbils. Infect Immun 76 (2008) 781-787
33. Maekawa T., Kinoshita Y., Matsushima Y., et al. Helicobacter pylori induces proinflammatory cytokines and major histocompatibility complex class II antigen in mouse gastric epithelial cells. J Lab Clin Med 130 (1997) 442-449
34. Ferrero R.L., Ave P., Ndiaye D., et al. NF-kappaB activation during acute Helicobacter pylori infection in mice. Infect Immun 76 (2008) 551-561
35. Shibata W., Takaishi S., Muthupalani S., et al. Conditional deletion of IkappaB-kinase-beta accelerates Helicobacter-dependent gastric apoptosis, proliferation, and preneoplasia. Gastroenterology 138 (2010) 1022-1034